Assessment of Tapentadol API Abuse Liability with the Researched Abuse, Diversion and Addiction-Related Surveillance (RADARS) System
• Abuse liability of tapentadol API is compared to those of other Scheduled opioids.• Population-level event rates of tapentadol API abuse were lower than comparators.• Drug-availability adjusted event rates of tapentadol abuse were low but not lowest.• Public health burden of tapentadol API appears to be low.
Source: The Journal of Pain - Category: Materials Science Authors: Suzanne K. Vosburg, S. Geoffrey Severtson, Richard C. Dart, Theodore J. Cicero, Steven P. Kurtz, Mark W. Parrino, Jody L. Green Tags: Original Report Source Type: research
More News: Addiction | International Medicine & Public Health | Materials Science | Pain | Substance Abuse